Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Sunscreen monograph

This article was originally published in The Tan Sheet

Executive Summary

Sunscreen monograph: Clinical testing standards for SPFs should use a 1 mg/cm2 or .5 mg/cm2 thickness of sunscreen to more closely approximate real-life use, Hans Christian Wulf, MD, Bispebjerg Hospital, Copenhagen, et al., state in Dec. 20 comments to FDA. The agency currently uses 2 mg/cm2 thickness as its standard for testing SPF; the European DIN uses 1.5 mg/cm2. The researchers propose the change based on a study of Danes sunbathing near Copenhagen, where people using sunscreens still experienced erythema. Lowering the thickness of sunscreen applied in testing, the researchers note, "would lower the SPF but make it more relevant to the practical situation and not only a ritual without any meaning"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086517

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel